88636116 - AC IMMUNE

Information

• Trademark
• 88636116

• Source

• Serial Number

  88636116

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  September 30, 2019
  6 years ago

• Transaction Date

  July 09, 2025
  10 months ago

• Status Date

  July 08, 2025
  11 months ago

• Published for Opposition Date

  May 13, 2025
  a year ago

• Location Date

  July 08, 2025
  11 months ago

• Status Code

  688

• Current Location

  INTENT TO USE SECTION

  Employee Name

  DETMER, CAROLYN

• Attorney Docket Number

  AC Immune

  Attorney Name

  Kristina Montanaro Schrader

  Law Office Assigned Location Code

  N90

• Owners

  • AC IMMUNE SA

Case File Statements

• DM0000: The mark consists of two interlocking circles to the left of the black text, "AC IMMUNE". One circle is yellow and the other circle is red. Where the circles interlock, they are orange. The outer edges of the circles are thinner than the inner portions of the circles. The color white represents background, outlining, shading, and/or transparent area and is not part of the mark.
• GS0051: Pharmaceuticals, medical and veterinary preparations for the diagnosis, prevention and treatment of neurodegenerative diseases and inflammatory diseases; diagnostic preparations and materials for medical or veterinary purposes; companion diagnostic agents, biomarkers, imaging agents, PET-Imaging compounds, all for medical purposes; chemical preparations for medical purposes, namely, for the diagnosis, prevention and treatment of neurodegenerative diseases and inflammatory diseases; chemico-pharmaceutical preparation for medical purposes, namely, for the diagnosis, prevention and treatment of neurodegenerative diseases and inflammatory diseases; antibodies, antibody fragments and antibody derivatives for use in disease testing, diagnosis, prevention and treatment for medical purposes; pharmaceutical and medical preparations in the nature of small molecule compounds for medical purposes; PET-Imaging compounds in the nature of diagnostic radiopharmaceutical agents for use in PET imaging; diagnostic preparations in the nature of companion compounds for medical use; pharmaceutical and medical preparations in the nature of biomarkers for medical purposes; vaccines; antigenic peptides for the diagnosis, prevention and treatment of neurodegenerative diseases and inflammatory diseases; pharmaceutical and medical preparations in the nature of protein or protein fragments for medical purposes; diagnostic reagents for medical purposes; diagnostic antibodies for medical purposes; none of the aforesaid goods relating to development of pharmaceutical therapies to prevent, manage, and treat food related, gastrointestinal, allergic and inborn error of metabolism diseases
• CC0000: The color(s) black, yellow, orange, and red is/are claimed as a feature of the mark.
• GS0011: Chemicals for use in industry and science; chemical substances, chemical materials and chemical preparations, and natural elements, namely, chemical preparations for industrial and scientific purposes, other than for medical or veterinary use; chemical, biochemical, biological and biotechnological preparations for use in industry and science; protein, protein fragments, amino acids, antibodies and fragments thereof for industrial, scientific or research purposes, other than for medical or veterinary use; chemical preparations comprising small molecules for use in industry and science; molecular libraries, comprising libraries of chemical preparations for use in industry and science; small molecule library, comprising libraries of chemical preparations for use in industry and science; antibody library, comprising libraries of antibodies for scientific or research use; reagents for use in the development of antibodies, proteins for binding or detecting antibodies and antibody-producing hybridoma cells for scientific or research purposes or for industrial use; detectably labelled compound for industrial, scientific purposes; diagnostic reagents for industrial, scientific or research purposes; immunological reagents for industrial, scientific or research purposes; biological cell, biological tissue culture for use in non-medical research laboratories; diagnostic tools in the nature of preparations, companion diagnostic agents, biomarkers, imaging agents, PET-Imaging compounds for industrial, scientific purposes other than for medical or veterinary use; diagnostic reagents for industrial, scientific or research purposes other than for medical or veterinary use; none of the aforesaid goods relating to development of pharmaceutical therapies to prevent, manage, and treat food related, gastrointestinal, allergic and inborn error of metabolism diseases
• DS0000: "IMMUNE"
• GS0421: Scientific and technological services, namely, scientific research, analysis and testing and the development of technology in the field of medicine and pharmaceuticals and research activities relating thereto; providing access to a proprietary technology platform containing antibodies, vaccines and small molecules that gives users the ability to obtain information for research purposes; biological research services; chemical research services in the fields of neurodegenerative diseases and inflammatory diseases; medical research services; scientific and medical laboratory services in biotechnology, chemistry, pharmacy, molecular science and immunotherapy; providing medical and scientific research information in the field of biotechnology, chemistry, pharmacy, molecular science, immunotherapy, therapeutics, diagnostics and clinical trials; scientific research, development and consultancy in the field of biotechnology, chemistry, pharmacy, molecular science, immunotherapy, therapeutics, diagnostics and clinical trials; development of test procedures, assays, test reagents, PET-imaging, companion diagnostic biomarkers, antibodies, vaccines and test kits for the field of biotechnology, chemistry, pharmacy, molecular science, immunotherapy, therapeutics, diagnostics and clinical trials; biological research, namely, screening and selection of pharmaceutical active substances from biological and biotechnological preparations; custom design and development of biological assays; research and development, namely, vaccine and antibody engineering; none of the aforesaid services relating to development of pharmaceutical therapies to prevent, manage, and treat food related, gastrointestinal, allergic and inborn error of metabolism diseases

Case File Event Statements

• 1/7/2020 - 6 years ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 10/3/2019 - 6 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 10/3/2019 - 6 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 10/4/2019 - 6 years ago

  3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC

• 1/3/2020 - 6 years ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 1/7/2020 - 6 years ago

  6 - NON-FINAL ACTION E-MAILED Type: GNRT

• 1/7/2020 - 6 years ago

  7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 7/2/2020 - 5 years ago

  8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 7/2/2020 - 5 years ago

  9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 7/3/2020 - 5 years ago

  10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 7/29/2020 - 5 years ago

  11 - SUSPENSION LETTER WRITTEN Type: CNSL

• 7/29/2020 - 5 years ago

  12 - LETTER OF SUSPENSION E-MAILED Type: GNSL

• 8/10/2021 - 4 years ago

  16 - INQUIRY TO SUSPENSION E-MAILED Type: GNSI

• 7/29/2020 - 5 years ago

  13 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3

• 7/6/2021 - 4 years ago

  14 - SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Type: RCCK

• 8/10/2021 - 4 years ago

  15 - SUSPENSION INQUIRY WRITTEN Type: CNSI

• 8/10/2021 - 4 years ago

  17 - NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Type: GNS2

• 1/27/2022 - 4 years ago

  18 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 1/27/2022 - 4 years ago

  19 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 1/27/2022 - 4 years ago

  20 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 1/27/2022 - 4 years ago

  21 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI

• 1/31/2022 - 4 years ago

  22 - ASSIGNED TO LIE Type: ALIE

• 2/9/2022 - 4 years ago

  23 - ASSIGNED TO LIE Type: ALIE

• 2/14/2022 - 4 years ago

  24 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN

• 2/14/2022 - 4 years ago

  25 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 2/14/2022 - 4 years ago

  26 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 4/27/2022 - 4 years ago

  27 - SUSPENSION LETTER WRITTEN Type: CNSL

• 4/27/2022 - 4 years ago

  28 - LETTER OF SUSPENSION E-MAILED Type: GNSL

• 4/27/2022 - 4 years ago

  29 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3

• 11/30/2022 - 3 years ago

  30 - SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Type: RCCK

• 12/4/2023 - 2 years ago

  31 - ASSIGNED TO EXAMINER Type: DOCK

• 12/6/2023 - 2 years ago

  32 - SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Type: RCCK

• 2/28/2024 - 2 years ago

  33 - SUSPENSION INQUIRY WRITTEN Type: CNSI

• 2/28/2024 - 2 years ago

  34 - INQUIRY TO SUSPENSION E-MAILED Type: GNSI

• 2/28/2024 - 2 years ago

  35 - NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Type: GNS2

• 5/16/2024 - 2 years ago

  36 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI

• 6/18/2024 - a year ago

  38 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 6/18/2024 - a year ago

  39 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 6/18/2024 - a year ago

  37 - ASSIGNED TO LIE Type: ALIE

• 12/23/2024 - a year ago

  44 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 12/23/2024 - a year ago

  45 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 12/23/2024 - a year ago

  43 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI

• 6/19/2024 - a year ago

  41 - LETTER OF SUSPENSION E-MAILED Type: GNSL

• 6/19/2024 - a year ago

  42 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3

• 6/19/2024 - a year ago

  40 - SUSPENSION LETTER WRITTEN Type: CNSL

• 1/6/2025 - a year ago

  47 - INQUIRY TO SUSPENSION E-MAILED Type: GNSI

• 1/6/2025 - a year ago

  48 - NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Type: GNS2

• 1/6/2025 - a year ago

  46 - SUSPENSION INQUIRY WRITTEN Type: CNSI

• 4/7/2025 - a year ago

  50 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 4/7/2025 - a year ago

  49 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI

• 4/7/2025 - a year ago

  51 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 4/8/2025 - a year ago

  52 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 4/17/2025 - a year ago

  53 - ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED Type: ERRR

• 5/7/2025 - a year ago

  54 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 5/13/2025 - a year ago

  55 - PUBLISHED FOR OPPOSITION Type: PUBO

• 5/13/2025 - a year ago

  56 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 7/8/2025 - 11 months ago

  57 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM